| Dr Michael G Wadzinski, MD | |
|
5855 Sunnybrook Dr., Sioux City, IA 51106 | |
| (712) 226-3937 | |
| (712) 224-3973 |
| Full Name | Dr Michael G Wadzinski |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 36 Years |
| Location | 5855 Sunnybrook Dr., Sioux City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982674297 | NPI | - | NPPES |
| 6301510 | Medicaid | SD | |
| 2106534 | Medicaid | IA | |
| 10025482400 | Medicaid | NE |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michael Wadzinski, Pc | 2062518756 | 2 |
| Michael Wadzinski, Pc | 2062518756 | 2 |
News Archive
AMRI today announced that it is repositioning itself to meet a continued shift in demand from customers for services in Asia and Europe. Overall for 2009 and 2010, the company anticipates investing in excess of $30 million on international facility and capability expansions and estimates its non-US workforce will increase by approximately 180 positions in order to meet known and anticipated customer demand.
Pre-treatment pain intensity is an independent survival predictor for patients with head and neck cancer, according to new research published in The Journal of Pain, the peer-reviewed publication of the American Pain Society.
In a major move, Kadcyla, a breast cancer drug that could prolong life expectancy and disease free survival among breast cancer patients is to be offered on NHS as a result of a deal between the health service and Pharmaceutical company Roche.
Installing alcohol-based hand sanitizer dispensers in the classrooms does not lead to reductions in the rate of school absences in children, according to a study published in this week's PLOS Medicine led by Patricia Priest and colleagues from the University of Otago, New Zealand.
The natural-occurring biopolymer known as chitosan is being put forward as an effective alternative to growth-promoting antibiotics in the diet of ruminants, according to research carried out by scientists at the Basque technological centre, Neiker-Tecnalia.
› Verified 4 days ago
| Entity Name | Michael Wadzinski, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629291992 PECOS PAC ID: 2062518756 Enrollment ID: O20070425000589 |
News Archive
AMRI today announced that it is repositioning itself to meet a continued shift in demand from customers for services in Asia and Europe. Overall for 2009 and 2010, the company anticipates investing in excess of $30 million on international facility and capability expansions and estimates its non-US workforce will increase by approximately 180 positions in order to meet known and anticipated customer demand.
Pre-treatment pain intensity is an independent survival predictor for patients with head and neck cancer, according to new research published in The Journal of Pain, the peer-reviewed publication of the American Pain Society.
In a major move, Kadcyla, a breast cancer drug that could prolong life expectancy and disease free survival among breast cancer patients is to be offered on NHS as a result of a deal between the health service and Pharmaceutical company Roche.
Installing alcohol-based hand sanitizer dispensers in the classrooms does not lead to reductions in the rate of school absences in children, according to a study published in this week's PLOS Medicine led by Patricia Priest and colleagues from the University of Otago, New Zealand.
The natural-occurring biopolymer known as chitosan is being put forward as an effective alternative to growth-promoting antibiotics in the diet of ruminants, according to research carried out by scientists at the Basque technological centre, Neiker-Tecnalia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael G Wadzinski, MD 5855 Sunnybrook Dr, Sioux City, IA 51106-4203 Ph: (712) 226-3937 | Dr Michael G Wadzinski, MD 5855 Sunnybrook Dr., Sioux City, IA 51106 Ph: (712) 226-3937 |
News Archive
AMRI today announced that it is repositioning itself to meet a continued shift in demand from customers for services in Asia and Europe. Overall for 2009 and 2010, the company anticipates investing in excess of $30 million on international facility and capability expansions and estimates its non-US workforce will increase by approximately 180 positions in order to meet known and anticipated customer demand.
Pre-treatment pain intensity is an independent survival predictor for patients with head and neck cancer, according to new research published in The Journal of Pain, the peer-reviewed publication of the American Pain Society.
In a major move, Kadcyla, a breast cancer drug that could prolong life expectancy and disease free survival among breast cancer patients is to be offered on NHS as a result of a deal between the health service and Pharmaceutical company Roche.
Installing alcohol-based hand sanitizer dispensers in the classrooms does not lead to reductions in the rate of school absences in children, according to a study published in this week's PLOS Medicine led by Patricia Priest and colleagues from the University of Otago, New Zealand.
The natural-occurring biopolymer known as chitosan is being put forward as an effective alternative to growth-promoting antibiotics in the diet of ruminants, according to research carried out by scientists at the Basque technological centre, Neiker-Tecnalia.
› Verified 4 days ago
Dr. Charles Earl Jones, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4405 Hamilton Blvd, Sioux City, IA 51104 Phone: 712-239-3937 Fax: 712-239-4946 | |
Dr. Yian Jin Jones, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4405 Hamilton Blvd, Sioux City, IA 51104 Phone: 712-239-3937 Fax: 712-239-4946 | |
Dr. Jason Jonathan Jones, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4405 Hamilton Blvd, Sioux City, IA 51104 Phone: 712-239-3937 Fax: 712-239-4946 |